The healthcare landscape is evolving fast and pharma must evolve with it. We require a fundamental rethink around the value we bring. This is not just about the technology or regulations, it’s about true understanding of the objectives to drive the future and partnerships for better patient outcomes.
At the 13th annual Pharma Japan Conference, pharma decision-makers will draw new blueprints for sustained commercial success. A combination of best digital practice, launch excellence, field force rejuvenation and cultural transformation is required to provide a kickstart. Join this event to breathe new life into your commercial approach.
|
Digital transformation: Recognise the need to digitize. Learn about new technologies. Focus on value with partnerships that deliver holistic patient outcomes. |
New commercial excellence models Transform your business model by ensuring you act decisively on customer insights. Utilise data to gaininsights to engage HCPs in a smart way. |
|
Deliver patient value to drive commercial & medical excellence Prove the authenticity of your medicine and care provision with robust data and a great story for HCPs and patient outcomes. |
|
Haider Alleg, Global Head of Digital Excellence / GMO, Ferring International Center
Reuters Events Pharma Japan is a thriving community of experts exchanging opinions and finding answers. You will meet peers who understand and will help to propel your ideas forward.
4 business-critical conference themes
Reuters Events Pharma Japan VIRTUAL 2020 will cover all key topics with four themes: Keynote, Digital Clinical Innovation, RWE & Medical and Commercial Excellence.
Online Networking
Connect with fellow senior-level attendees in a personalized and user-friendly way. Even you are at your home, we can come together and work towards a better pharma through live Q&A, online networking and workshop sessions.
The most senior-level pharma event in Japan
You won’t find a better place to meet your peers since over 80% of the pharma attendees are director-level or above.
Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it.
77% of attendees are director-level and above
Reuters Events Pharma Japan attracts a variety of job titles, geographies, cultures and opinions create a rich tapestry.
Satoru Noguchi, Ex-executive Pharma and Principal, GlobalMindset
As times change, Reuters Events Pharma Japan always captures the current and future trends to help us grow our business.
Haider Alleg, Global Head of Digital Excellence / GMO, Ferring International Center
Reuters Events Pharma Japan is a thriving community of experts exchanging opinions and finding answers. You will meet peers who understand and will help to propel your ideas forward.
Yasuyuki Katayama, Corporate Officer, Country Medical Director and Head of Medical Japan, Pfizer Japan Inc.
Reuters Events Pharma Japan is where leaders gather and find direction, opportunities and partnerships.
Katsunori Ohyama, Director, Severe asthma dedicated sales force, GlaxoSmithKline K.K.
Reuters Events Pharma Japan is always at the forefront of the pharma industry’s next movement.
Craig Lipset, former Head of Innovation at Pfizer
Now more than ever, society is looking to medicine developers for answers. Quickly moving important gatherings online is vital for innovation continuity and keeping us all making progress for delivering new medicines.
Get in touch with the Reuters Events: Pharma Management Team Japan
Kana Chia Head of Japan
Hiromasa Araki Business Development Executive, Japan
Blair Gottscho VP Operations
Izzy Gladstone Head of Marketing
Henry Payne Director of Business Development
